Anti-infective evasion and pharmacoepidemiology

Anti-infective evasion and pharmacoepidemiology

Our research activities focus on adverse and paradoxical events of therapeutic products:

  • The development of the epidemiology of health products, including drugs and medical devices. The emphasis is on medications with a strong public health impact (antibiotics, vaccines), and on any products largely used in population and/or suspected to be responsible of severe adverse effects.
  • The study of the effects of population exposure to antibiotics and vaccines on infectious risk, bacterial resistance to antibiotics, and vaccine evasion, both in the community and in hospitals.

Localisation

UFR de santé Simone VeilMontigny Le Bretonneux


Membres

Salam
ABBARA
Doctorant.e
Epidémiologiste
Joel
ANKRI
Chercheur.se
Epidémiologiste
Wilfried
BARA
Doctorant.e
Epidémiologiste
Catherine
BILLARD
Chercheur.se
Economiste de la santé
Christian
BRUN-BUISSON
Epidémiologiste
Elisabeth
DELAROCQUE-ASTAGNEAU
Chercheur.se
Epidémiologiste
Aurélien
DINH
Doctorant.e
Epidémiologiste
Solène
DRUSCH
Doctorant.e
Epidémiologiste
Lamiae
GRIMALDI
Chercheur.se
Epidémiologiste
Didier
GUILLEMOT
Chercheur.se
Responsable d'équipe
Paul
HENRIOT
Ingénieur.e. ou technicien.ne
Ingénieur biologiste traitement de données
Marie
HERR-BREGET
Chercheur.se
Epidémiologiste
Bich-Tram
HUYNH
Chercheur.se
Epidémiologiste
Esso-Dong epiphane
KOLLA
Doctorant.e
Epidémiologiste
Aleksandra
KOVACEVIC
Chercheur.se
Epidémiologiste
Caroline
LABORDE
Doctorant.e
Socio-démographe
Ajmal
OODALLY
Chercheur.se
Autre
Lulla
OPATOWSKI
Chercheur.se
Epidémiologiste
Fanny
PANDOLFI
Chercheur.se
Epidémiologiste
Eve
RAHBE
Doctorant.e
Autre
Lison
RAMBLIERE
Doctorant.e
Epidémiologiste
Noemie
ROLAND
Doctorant.e
Epidémiologiste
Georges
SHIRREFF
Chercheur.se
Autre
David
SMITH
Doctorant.e
Biostatisticien.ne
Laurence
WATIER
Chercheur.se
Biostatisticien.ne
Mahmoud
ZUREIK
Chercheur.se
Epidémiologiste

Dernières publications

Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria. Mehdi Touat, Christian Brun-Buisson, Marion Opatowski, Jérôme Salomon, Didier Guillemot, Philippe Tuppin, Grégoire de Lagasnerie, Laurence Watier. . 2021; : . doi: 10.1016/j.jinf.2021.02.001
Article
Lockdown impact on age-specific contact patterns and behaviours in France. Paolo Bosetti , Bich-Tram Huynh , Armiya Youssouf Abdou , Marie Sanchez , Catherine Eisenhauer , Noémie Courtejoie , Jérôme Accardo , Henrik Salje , Didier Guillemot , Mathieu Moslonka-Lefebvre , Pierre-Yves Boëlle , Guillaume Béraud , Simon Cauchemez , Lulla Opatowski. MedRxiv. 2020; : . doi:https://doi.org/10.1101/2020.10.07.20205104
Article
Optimizing COVID-19 surveillance in longterm care facilities: a modelling study. David R. M. Smith, Audrey Duval, Koen B. Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, Laura Temime, Lulla Opatowski & on behalf of the AP-HP/Universities/Inserm COVID-19 research collaboration. BMC Medicine. 2020; : . doi:10.1186/s12916-020-01866-6
Article
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France. Mahmoud Zureik , Berangere Baricault , Célementine Vabre , Laura SEMENZATO , Jérôme Drouin , François cuenot , Laetitia penso , Philippe Herlemont , Emilie Sbidian , Alain Weill , Mathieu Molimard , Rosemary Dray-Spira , Jeremie Botton. MedRxiv. 2020; : . doi:10.1101/2020.07.28.20160630
Article